Charles River Laboratories International Inc CRL:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:38 AM EDT
235.29quote price arrow up+1.82 (+0.78%)
Volume
18,344
52 week range
161.65 - 275.00
Loading...
  • Open235.60
  • Day High235.60
  • Day Low233.97
  • Prev Close233.47
  • 52 Week High275.00
  • 52 Week High Date03/08/24
  • 52 Week Low161.65
  • 52 Week Low Date11/01/23

Key Stats

  • Market Cap12.12B
  • Shares Out51.51M
  • 10 Day Average Volume0.52M
  • Dividend-
  • Dividend Yield-
  • Beta1.43
  • YTD % Change-0.42

KEY STATS

  • Open235.60
  • Day High235.60
  • Day Low233.97
  • Prev Close233.47
  • 52 Week High275.00
  • 52 Week High Date03/08/24
  • 52 Week Low161.65
  • 52 Week Low Date11/01/23
  • Market Cap12.12B
  • Shares Out51.51M
  • 10 Day Average Volume0.52M
  • Dividend-
  • Dividend Yield-
  • Beta1.43
  • YTD % Change-0.42

RATIOS/PROFITABILITY

  • EPS (TTM)9.23
  • P/E (TTM)25.49
  • Fwd P/E (NTM)21.34
  • EBITDA (TTM)967.261M
  • ROE (TTM)14.44%
  • Revenue (TTM)4.129B
  • Gross Margin (TTM)36.89%
  • Net Margin (TTM)11.63%
  • Debt To Equity (MRQ)73.75%

EVENTS

  • Earnings Date05/09/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Charles River Laboratories International Inc

 

Profile

MORE
Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. The Company's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its clients to discover new molecules: Research Models, Research Model Services, and Cell...
James Foster J.D.
Chairman of the Board, President, Chief Executive Officer
Birgit Girshick
Chief Operating Officer, Corporate Executive Vice President
Flavia Pease
Chief Financial Officer, Corporate Executive Vice President
Shannon Parisotto
Corporate Executive Vice President - Discovery and Safety Assessment Management
Joseph LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
Address
251 Ballardvale St
Wilmington, MA
01887
United States

Top Peers

SYMBOLLASTCHG%CHG
INCY
Incyte Corp
53.79+0.03+0.06%
EXAS
Exact Sciences Corp
63.52+1.45+2.34%
ILMN
Illumina Inc
117.96+0.03+0.03%
MEDP
Medpace Holdings Inc
402.24+9.67+2.46%
NBIX
Neurocrine Biosciences Inc
141.72+1.01+0.72%